The Board of Pharmacy issued a response to Gov. Kim Reynolds’ (R) October 16 Proclamation of Disaster Emergency. All previous pharmacy regulatory relief provisions remain in place through November 15, 2020.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
In the wake of Gov. Gretchen Whitmer’s Executive Orders being rescinded with immediate effect by the State Supreme Court, legislation to authorize COVID-19 testing by pharmacists has cleared both the House and Senate. HB 6293 now heads to the Governor. NACDS and partners continue to work with SB 920 as a possible vehicle for restoring other rescinded regulatory relief.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
The Missouri COVID-19 Vaccinator Enrollment program is now open. Beginning Wednesday, October 28 at 8:00 a.m., providers will be required to utilize Missouri’s Immunization Information System, ShowMeVax, to complete the enrollment process. Tools and instruction can be found here, as is the Memorandum of Agreement form required for new providers. Questions about the enrollment process can be asked here.
Also in Missouri. Applications are now being accepted for the Rx Cares for Missouri Medication Destruction Program. Applications and a Program Guide can be found on the Board of Pharmacy website. Current program participants do not have to re-enroll. Enrollment is limited.
Also in Missouri. The Department of Health and Senior Services announced enhancements to ShowMeVax, Missouri’s web-based immunization information system. In early 2021, the current ShowMeVax daily data feeds into the enhanced ShowMeVax will cease. According to the Department, all providers wishing to continue exchanging vaccination data with the new system will need to register here. Questions about the transition can be addressed to the HL7 On-boarding team.
Lastly in Missouri. The Board of Pharmacy issued a proposed rule to adopt regulations under 20 CSR 2220-2 to establish licensing requirements and compliance standards for Class R remote dispensing site pharmacies. The rule would authorize the preparation, dispensing, and compounding of medication for patient dispensing without a pharmacist physically present at the Class R site to monitor and supervise pharmacy activities. The rule also would establish supervisory requirements. The proposal currently is in effect as an emergency rule. Comments are due November 14, 2020.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
The Ohio Department of Health and the Governor’s Pandemic Response and Recovery Leadership Team created a webinar on how to participate in the Ohio COVID-19 Vaccine Program. This webinar is now available on-demand and provides an overview of Ohio’s proposed vaccination strategy, as well as detailed instructions if you choose to become a provider of the COVID-19 vaccine when it becomes available. Please submit any questions you have to covidvaccine@ODH.ohio.gov.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Department of Health and Social Services announced a new statewide standing order issued by Mary S. Carpenter, M.D., for Naloxone distribution from pharmacies. Per the standing order, Naloxone can now be requested and dispensed by pharmacists in South Dakota to any person who is an individual at risk of experiencing an opioid-related overdose and/or a family member, friend, or close third-party to a person at risk of experiencing an opioid-related overdose. Detailed information and supporting documents and forms regarding the standing order and Naloxone distribution can be found by accessing www.AvoidOpioidSD.com/pharmacy. For further questions, please contact the SD DSS, Division of Behavioral Health at avoidopioid@state.sd.us, or call 605-367-5236.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
The Governor’s Task Force on the Reducing Prescription Drug Prices, created per Gov. Tony Evers’ (D) Executive Order #39, issued its final report. Please recall NACDS submitted comments in August focusing on post-adjudication fees and drug importation. The primary recommendation from the Task Force is to advance 2019 AB 114/SB 100, PBM legislation introduced by the Pharmacy Society of Wisconsin among whose provisions include prohibiting post-adjudication fees.
Also in Wisconsin. Forward Health issued a bulletin with reminders about how pharmacies should bill for providing vaccinations.
Also in Wisconsin. The Department of Health Services is proposing to add coverage of vaccinations to the SeniorCare program, which serves approximately 93,000 individuals monthly. Comments are being accepted through November 2, 2020.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
Gov. Asa Hutchison (R) appointed Rodney Richmond MS, PharmD, BCGP, FASCP to serve a six-year term on the eight-member Board of Pharmacy. Richmond is filling the seat previously held by Dr. Steve Bryant.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
After a lengthy discussion on October 20, the Board of Pharmacy’s Licensing Committee unanimously supported two motions to be considered by the full Board:
These proposals will be considered at the full Board of Pharmacy teleconference meeting on October 27 & 28, 2020. The meeting agenda can be found here and additional meeting materials are available here.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy released a proposed rule to repeal regulations under FAC 64B16-27 regarding ordering and evaluation of laboratory tests. Comments and hearing requests are due on October 28, 2020.
Also in Florida. The Board of Pharmacy released a final rule to adopt regulations under FAC 64B16-31 to establish standards for the collaborative practice certification and the test and treat certification. The rule addresses initial certification courses, agreement, and written protocol standards, formulary of medicinal drugs, patient records, follow-up care, and continuing education. The rule is effective on October 28, 2020.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.